drugset / Trial / NCT01335724

Efficacy and Safety of Diclofenac 1.16% Gel in Subjects With Acute Neck Pain

NCT01335724 ↗

Phase 4 Completed 72 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of diclofenac 1.16% gel compared with placebo applied four times a day in subjects with acute neck pain.

Timeline

Start
2011-04
Primary completion
2011-07
Completion
2011-07

Outcome

Met primary endpoint

paper The primary outcome, POM at 48 h, was statistically significantly lower with DDEA gel (19.5 mm) vs. placebo (56.9 mm) (p < 0.0001). PMID 23964752 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 2 g Topical

Indications

No indication recorded.